Taysha Gene Therapies Stock (TSHA): Why The Price Increased Today

By Amit Chowdhry ● Dec 9, 2021
  • The stock price of Taysha Gene Therapies Inc (NASDAQ: TSHA) increased by over 7% during intraday trading today. This is why it happened.

The stock price of Taysha Gene Therapies Inc (NASDAQ: TSHA) increased by over 7% during intraday trading today. Investors are responding positively to a Form 4 filing from the company. 

The Form 4 filing reveals that RA Session II, the President, CEO and Founder of Taysha Gene Therapies, acquired a couple of large positions in the company. These are the transactions:

— 16,510 shares acquired for $12.12

— 26,008 shares acquired for $12.65

With these transactions, RA Session II now owns 9,190,920 shares of the company.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.